LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,717,000 | -42.5% | 100,000 | -40.9% | 0.08% | -43.2% |
| Q2 2023 | $11,687,124 | +84.4% | 169,305 | +28.8% | 0.14% | +61.6% |
| Q1 2023 | $6,338,037 | -8.6% | 131,440 | -5.4% | 0.09% | -7.5% |
| Q4 2022 | $6,937,233 | +29.3% | 138,967 | +5.7% | 0.09% | +24.0% |
| Q3 2022 | $5,365,000 | -91.7% | 131,500 | -88.8% | 0.08% | -92.4% |
| Q2 2022 | $64,408,000 | +51.3% | 1,171,051 | 0.0% | 0.99% | +43.7% |
| Q1 2022 | $42,556,000 | -38.3% | 1,171,051 | -20.8% | 0.69% | -30.0% |
| Q4 2021 | $68,921,000 | -7.8% | 1,478,666 | +0.0% | 0.99% | -19.2% |
| Q3 2021 | $74,758,000 | +567.0% | 1,478,594 | +441.5% | 1.22% | +484.2% |
| Q2 2021 | $11,208,000 | -7.7% | 273,043 | -36.7% | 0.21% | -35.1% |
| Q4 2020 | $12,149,000 | +47.2% | 431,418 | +122.5% | 0.32% | -1.5% |
| Q2 2020 | $8,251,000 | – | 193,857 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
| HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
| Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
| RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
| Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
| Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
| Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
| Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
| E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |